WINTON GROUP Ltd decreased its holdings in Centene Co. (NYSE:CNC – Get Rating) by 43.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,968 shares of the company’s stock after selling 4,503 shares during the quarter. WINTON GROUP Ltd’s holdings in Centene were worth $505,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Huntington National Bank lifted its position in Centene by 30.8% during the 1st quarter. Huntington National Bank now owns 1,309 shares of the company’s stock worth $110,000 after acquiring an additional 308 shares during the period. Whittier Trust Co. lifted its position in Centene by 4.4% during the 1st quarter. Whittier Trust Co. now owns 2,981 shares of the company’s stock worth $251,000 after acquiring an additional 125 shares during the period. Gateway Investment Advisers LLC lifted its position in Centene by 16.5% during the 2nd quarter. Gateway Investment Advisers LLC now owns 8,887 shares of the company’s stock worth $752,000 after acquiring an additional 1,257 shares during the period. Metis Global Partners LLC lifted its position in Centene by 81.3% during the 1st quarter. Metis Global Partners LLC now owns 9,225 shares of the company’s stock worth $776,000 after acquiring an additional 4,136 shares during the period. Finally, Kentucky Retirement Systems lifted its position in Centene by 5.2% during the 1st quarter. Kentucky Retirement Systems now owns 37,193 shares of the company’s stock worth $3,131,000 after acquiring an additional 1,853 shares during the period. Institutional investors and hedge funds own 94.74% of the company’s stock.
Centene Price Performance
NYSE:CNC opened at $82.68 on Friday. Centene Co. has a 12 month low of $69.51 and a 12 month high of $98.53. The stock has a 50 day moving average of $80.71 and a two-hundred day moving average of $84.89. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.71. The firm has a market cap of $46.82 billion, a P/E ratio of 24.10, a price-to-earnings-growth ratio of 1.04 and a beta of 0.60.
Analyst Ratings Changes
Several brokerages have recently issued reports on CNC. Argus began coverage on Centene in a report on Friday, September 30th. They issued a “buy” rating and a $90.00 price objective for the company. Truist Financial boosted their price objective on Centene from $102.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, July 27th. Cowen decreased their price objective on Centene from $108.00 to $101.00 in a report on Thursday, September 22nd. Cowen decreased their price objective on Centene from $108.00 to $101.00 in a report on Thursday, September 22nd. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on Centene from $99.00 to $94.00 in a report on Wednesday, October 26th. Four analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Centene has a consensus rating of “Moderate Buy” and an average price target of $98.68.
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs.
- Get a free copy of the StockNews.com research report on Centene (CNC)
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
- How High Can the Fed Go? How to Trade it
- Does ASML’s November Rally Have Staying Power?
- Verra Mobility Stock Has Returned Back to the Station
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.